Eli Lilly ($LLY) and Novo Nordisk ($NVO) just got the Trump trade blessing.
✅ GLP-1 drugs now $149/month through TrumpRx
✅ Medicare & Medicaid coverage confirmed
✅ 3-year tariff reprieve for both pharma giants
✅ $37B combined U.S. investment commitment
Why it matters:
This is the rotation moment. Pharma is about to lead while semiconductors and consumer stocks fade. Extreme fear readings (27/100) + policy tailwinds = perfect setup for bullish momentum.
💡 Trade Focus:
$LLY: Entry $195–200 → Target $210–220
$NVO: Watch for $160+ breakout on open
👉 Discussion: Are you riding the pharma wave or still holding tech bags?